Literature DB >> 31394409

Characterization of de novo lytic infection of dermal lymphatic microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus.

Gavin Golas1, Juan D Alonso1, Zsolt Toth2.   

Abstract

The biology of primary lytic Kaposi's sarcoma-associated herpesvirus (KSHV) infection is still not well understood, which is largely attributed to the lack of cell lines permissive to robust lytic KSHV infection in vitro. Our study demonstrates that primary human dermal lymphatic microvascular endothelial cells (HDLMEC) support lytic KSHV replication following de novo infection, resulting in robust KSHV production, indicating that HDLMECs are suitable for studying the regulation of primary lytic KSHV infection. Importantly, by utilizing lytically infected HDLMECs, we show for the first time that the KSHV latent genes LANA and viral cyclin are required for lytic replication during de novo lytic infection, a function of these latent genes that has not yet been recognized. Since Kaposi's sarcoma is considered to be originated from infected lymphatic endothelial cells, HDLMECs represent a valuable in vitro cell culture model for investigating lytic KSHV infection, which has been understudied in KSHV pathogenesis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Herpesvirus; KSHV; Latent genes; Lymphatic endothelial cells; Lytic infection

Mesh:

Substances:

Year:  2019        PMID: 31394409      PMCID: PMC6733618          DOI: 10.1016/j.virol.2019.07.028

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  35 in total

Review 1.  Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.

Authors:  Ethel Cesarman
Journal:  Cancer Lett       Date:  2011-04-13       Impact factor: 8.679

2.  Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor.

Authors:  Pei-Ching Chang; Mengtao Li
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

3.  Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.

Authors:  Subhash C Verma; Ke Lan; Tathagata Choudhuri; Erle S Robertson
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells.

Authors:  Shou-Jiang Gao; Jian-Hong Deng; Fu-Chun Zhou
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.

Authors:  Bernadett Papp; Naeem Motlagh; Richard J Smindak; Seung Jin Jang; Aria Sharma; Juan D Alonso; Zsolt Toth
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

6.  Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.

Authors:  Grzegorz Sarek; Annika Järviluoma; Henna M Moore; Sari Tojkander; Salla Vartia; Peter Biberfeld; Marikki Laiho; Päivi M Ojala
Journal:  PLoS Pathog       Date:  2010-03-19       Impact factor: 6.823

7.  Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.

Authors:  Harinivas H Krishnan; Pramod P Naranatt; Marilyn S Smith; Ling Zeng; Clark Bloomer; Bala Chandran
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator.

Authors:  Hiroyuki Nakamura; Michael Lu; Yousang Gwack; John Souvlis; Steven L Zeichner; Jae U Jung
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells.

Authors:  Karen M Duus; Vivian Lentchitsky; Timothy Wagenaar; Charles Grose; Jennifer Webster-Cyriaque
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates latency-associated nuclear protein-mediated suppression of lytic origin-dependent DNA synthesis.

Authors:  Cyprian Rossetto; Irena Yamboliev; Gregory S Pari
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

View more
  8 in total

1.  Comparative analysis of the viral interferon regulatory factors of KSHV for their requisite for virus production and inhibition of the type I interferon pathway.

Authors:  Gavin Golas; Seung Jin Jang; Nenavath Gopal Naik; Juan D Alonso; Bernadett Papp; Zsolt Toth
Journal:  Virology       Date:  2019-12-30       Impact factor: 3.616

2.  The Lymphatic Cell Environment Promotes Kaposi Sarcoma Development by Prox1-Enhanced Productive Lytic Replication of Kaposi Sarcoma Herpes Virus.

Authors:  Dongwon Choi; Eunkyung Park; Kyu Eui Kim; Eunson Jung; Young Jin Seong; Luping Zhao; Shrimika Madhavan; George Daghlian; Hansuh H Lee; Patill T Daghlian; Saren Daghlian; Khoa Bui; Chester J Koh; Alex K Wong; Il-Taeg Cho; Young-Kwon Hong
Journal:  Cancer Res       Date:  2020-06-09       Impact factor: 12.701

3.  KSHV requires vCyclin to overcome replicative senescence in primary human lymphatic endothelial cells.

Authors:  Terri A DiMaio; Daniel T Vogt; Michael Lagunoff
Journal:  PLoS Pathog       Date:  2020-06-18       Impact factor: 6.823

Review 4.  Clinical Manifestations and Epigenetic Regulation of Oral Herpesvirus Infections.

Authors:  Natalie Atyeo; Michelle D Rodriguez; Bernadett Papp; Zsolt Toth
Journal:  Viruses       Date:  2021-04-15       Impact factor: 5.048

5.  Kaposi's sarcoma herpesvirus activates the hypoxia response to usurp HIF2α-dependent translation initiation for replication and oncogenesis.

Authors:  Omayra Méndez-Solís; Mourad Bendjennat; Julian Naipauer; Phaedra R Theodoridis; J J David Ho; Ramiro E Verdun; Joshua M Hare; Ethel Cesarman; Stephen Lee; Enrique A Mesri
Journal:  Cell Rep       Date:  2021-12-28       Impact factor: 9.995

Review 6.  The ORF45 Protein of Kaposi's Sarcoma-Associated Herpesvirus and Its Critical Role in the Viral Life Cycle.

Authors:  Natalie Atyeo; Bernadett Papp
Journal:  Viruses       Date:  2022-09-11       Impact factor: 5.818

7.  Oncogenic Herpesvirus Engages Endothelial Transcription Factors SOX18 and PROX1 to Increase Viral Genome Copies and Virus Production.

Authors:  Krista Tuohinto; Veijo Nurminen; Silvia Gramolelli; Endrit Elbasani; Thomas Günther; Riikka E Kallinen; Seppo P Kaijalainen; Raquel Diaz; Adam Grundhoff; Caj Haglund; Joseph M Ziegelbauer; Teijo Pellinen; Mark Bower; Mathias Francois; Päivi M Ojala
Journal:  Cancer Res       Date:  2020-06-09       Impact factor: 12.701

8.  PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment.

Authors:  Julian Naipauer; Santas Rosario; Sachin Gupta; Courtney Premer; Omayra Méndez-Solís; Mariana Schlesinger; Virginia Ponzinibbio; Vaibhav Jain; Lauren Gay; Rolf Renne; Ho Lam Chan; Lluis Morey; Daria Salyakina; Martin Abba; Sion Williams; Joshua M Hare; Pascal J Goldschmidt-Clermont; Enrique A Mesri
Journal:  PLoS Pathog       Date:  2019-12-27       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.